Back to search

Article

Genome-wide Mendelian randomization and multi-omics integration identify drug targets for irritable bowel syndrome

2024-01-18

Abstract excerpt

<h4>Introduction: </h4> Irritable bowel syndrome (IBS) is a common chronic functional gastrointestinal disorder. Despite the intricate and varied range of symptoms, there are now no recognized effective therapeutic methods. Mendelian randomization (MR) is a commonly employed method for repurposing existing licensed medications and identifying novel therapeutic targets. Hence, our objective was to discover new trea...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cb3219d1-f5b3-5fbd-84f1-c6a48a722acc
DOI
10.21203/rs.3.rs-3800640/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Genome-wide Mendelian randomization and multi-omics integration identify drug targets for irritable bowel syndromeDOI 10.21203/rs.3.rs-3800640/v1
Select a neighboring publication to make it the new centre.